摘要 |
An agent having a greater half-life than naturally produced albumin in a patient with NS, the agent comprising an albumin-like first polypeptide bound to a second polypeptide, wherein the second polypeptide, when bound to the albumin-like first polypeptide is therapeutically inert and wherein if the agent consists of two albumin molecules, then they are covalently joined to one another other than solely by means of one or more cysteine-cysteine disulphide bridges.
|